Because many of the most severe brain diseases and injuries involve damage to or death of brain cells, cell based therapies to repair the brain are attractive. Traditionally, cellular therapy has been conceived to entail injections or transplants of exogenous cells into recipients, either within or adjacent to the insult, or systemically. However, endogenous stem cell niches have been characterized, both in animals and in humans, and may present a therapeutic reservoir for cellular therapy. Here I propose innovative methods for steering large numbers of endogenous neural progenitor cells to areas of experimental stroke in somatosensory cortex in rodents. The stroke model will be the endothelin-1 induced vasoconstriction model. Following the stroke, neural progenitor cells will be labeled with MRI contrast agent directly in vivo. Next, these endogenous stem cells will be chemically manipulated, in vivo, first enhancing stem cell proliferation, then directing the migration of neuroblasts to stroke sites. In vivo cell tracking will be performed using high resolution magnetic resonance imaging, allowing the monitoring of therapeutic progress both spatially and longitudinally. Imaging data will be correlated to immunohistochemistry. Functional magnetic resonance imaging will be used to investigate restoration of function in the stroke sites due to the experimental therapeutic regiment and will be compared to standard behavioral assessments. If successful, significant impact can be achieved on stem cell therapy by realizing the full potential of a relatively unexplored source of therapeutic stem cells, the endogenous stem cells. However, equally important will be the further development and refinement of MRI methods for detecting single cells, in vivo. It is clear that cell therapy in humans will be greatly aided by the use of non-invasive methods for monitoring cell position and fate. The magnetic resonance imaging methods developed here will facilitate and expedite eventual human clinical applications.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
1DP2OD004362-01
Application #
7598907
Study Section
Special Emphasis Panel (ZGM1-NDIA-G (01))
Program Officer
Basavappa, Ravi
Project Start
2008-09-30
Project End
2012-06-30
Budget Start
2008-09-30
Budget End
2012-06-30
Support Year
1
Fiscal Year
2008
Total Cost
$2,363,621
Indirect Cost
Name
Yale University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Afridi, Muhammad Jamal; Ross, Arun; Liu, Xiaoming et al. (2017) Intelligent and automatic in vivo detection and quantification of transplanted cells in MRI. Magn Reson Med 78:1991-2002
Blanco-Fernandez, Barbara; Chakravarty, Shatadru; Nkansah, Michael K et al. (2016) Fabrication of magnetic and fluorescent chitin and dibutyrylchitin sub-micron particles by oil-in-water emulsification. Acta Biomater 45:276-285
Shapiro, Erik M (2015) Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn Reson Med 73:376-89
Granot, Dorit; Nkansah, Michael K; Bennewitz, Margaret F et al. (2014) Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking. Magn Reson Med 71:1238-50
Granot, Dorit; Shapiro, Erik M (2014) Accumulation of micron sized iron oxide particles in endothelin-1 induced focal cortical ischemia in rats is independent of cell migration. Magn Reson Med 71:1568-74
Swy, Eric R; Schwartz-Duval, Aaron S; Shuboni, Dorela D et al. (2014) Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography. Nanoscale 6:13104-12
Pirazzoli, Valentina; Nebhan, Caroline; Song, Xiaoling et al. (2014) Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Cell Rep 7:999-1008
Bennewitz, Margaret F; Williams, Simone S; Nkansah, Michael K et al. (2013) Poly(lactic-co-glycolic acid) encapsulated gadolinium oxide nanoparticles for MRI-based cell tracking. J Nanosci Nanotechnol 13:3778-83
Tang, Kevin S; Hashmi, Sarah M; Shapiro, Erik M (2013) The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling. Nanotechnology 24:125101
Bennewitz, Margaret F; Tang, Kevin S; Markakis, Eleni A et al. (2012) Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma. Mol Imaging Biol 14:676-87

Showing the most recent 10 out of 16 publications